Novo Nordisk A/S
NONOF
$48.02
-$0.65-1.34%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.95% | 24.06% | 15.82% | 20.61% | 27.14% |
| Total Depreciation and Amortization | 69.68% | 38.88% | 4.35% | -10.87% | -7.06% |
| Total Amortization of Deferred Charges | 18.52% | 18.52% | 18.52% | 18.52% | 14.80% |
| Total Other Non-Cash Items | -26.06% | 47.88% | 304.31% | -17.13% | 44.15% |
| Change in Net Operating Assets | 21.48% | -2,148.18% | -46.21% | 7.28% | -706.06% |
| Cash from Operations | 8.38% | 6.93% | 39.31% | 11.11% | 11.55% |
| Capital Expenditure | -45.36% | -65.74% | -74.13% | -82.46% | -91.96% |
| Sale of Property, Plant, and Equipment | -196.95% | -- | -- | -- | -- |
| Cash Acquisitions | -11,983.50% | -11,983.50% | -- | -- | 90.08% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 200.60% | 144.40% | -51.64% | 101.63% | 22.54% |
| Cash from Investing | -143.57% | -196.96% | -314.30% | -190.78% | -23.89% |
| Total Debt Issued | 240.93% | 240.38% | -- | -- | 36,354.74% |
| Total Debt Repaid | -1,154.08% | -1,200.60% | -1,282.08% | -331.83% | -368.34% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 60.45% | 56.91% | 32.03% | 32.56% | 18.96% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -17.53% | -18.84% | -18.84% | -40.21% | -40.21% |
| Other Financing Activities | -- | -- | 1,008.73% | -- | -- |
| Cash from Financing | 34.41% | 35.92% | 157.07% | 112.20% | 36.00% |
| Foreign Exchange rate Adjustments | 66.65% | -294.17% | 62.40% | 485.36% | 32.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -192.12% | -213.65% | 482.86% | -12.51% | 841.37% |